X0508 4 2025-11-13 0001422143 Kura Oncology, Inc. KURA 0001813058 Bair Teresa Brophy C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500 SAN DIEGO CA 92121 false true false false Chief Legal Officer true Common Stock 2025-11-13 4 A false 48900 0 A 196943 D Common Stock 2025-11-14 4 S false 8804 11.1769 D 188139 D Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares. /s/ Teresa Bair 2025-11-14